SCHEMBL30903276

CSCC[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	CXCL8	P10145	10/20	0.60

▸	NPY1R	P25929	1/20	0.58

▸	NPY2R	P49146	1/20	0.58

▸	NPY4R	P50391	1/20	0.58

▸	NPY5R	Q15761	1/20	0.58

▸	C5AR1	P21730	2/20	0.58

▸	MC4R	P32245	1/20	0.58

▸	MC5R	P33032	1/20	0.58

▸	MC3R	P41968	1/20	0.58

▸	MC1R	Q01726	1/20	0.58

▸	GLP1R	P43220	3/20	0.57

▸	GCGR	P47871	3/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29609518	0.98	CXCL8 (0.62)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL29461409	0.98	CXCL8 (0.59)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL30903278	0.96	MC4R (0.59)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL30903290	0.87	CCKBR (0.59)	CXCL8GLP1RGCGR
SCHEMBL30567758	0.86	NPY1R (0.68)	NPY1RNPY2RNPY4RNPY5RGLP1R
SCHEMBL30812405	0.85	IL23R (0.62)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL30598998	0.84	C5AR1 (0.58)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182901	0.84	CXCR4 (0.62)	CXCL8NPY1RNPY2RNPY4RNPY5R
SCHEMBL30186411	0.84	MC4R (0.66)	CXCL8C5AR1MC4RMC5RMC3R
SCHEMBL31000888	0.84	NPY1R (0.68)	NPY1RNPY2RNPY4RNPY5RC5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240148849-A1	IMMUNOGENIC COMPOSITION, USE AND METHODS	GLAXOSMITHKLINE BIOLOGICALS SA (BE)	2024-05-09	—	—	US	disclosed